Onboard hemolysis with whole blood to improve working efficiency
No manual pretreatment to reduce biohazardous risks and human errors
120 T/H for HbA1c test to shorten turn-around-time
Mindray HbA1c reagent with enzymatic method can specifically detect glycated N-terminal amino acids from the hemoglobin beta-chains, which can effectively avoid interference from Hb variants (HbS, HbC, HbE and HbD) and other Hb derivatives (labile HbA1c, carbamylated Hb, and acetylated Hb).
Mindray enzymatic HbA1c gives reliable and cost efficient result with the first measurement and reduce further confirmations.
Lower Hb Detection Limit for HbA1c Test
Evaluate the Hb concentration in the process of hemolysis and start sample increasement tests in advance for low Hb concentration samples. This function can lower the detection limit and expand linearity range Hb to reduce the rerun rate and reagent waste for anemia samples.
High Level Sigma Metric Performance
Original reagents and validated application protocol lower the inaccuracy and imprecision which contributes to achieving world-class and excellent sigma metric performance.
Higher sigma level system can help laboratories offer high level of quality at reduced cost and enhance clinician confidence and satisfaction.
Intelligent Abnormal Reaction Detection
Powerful software with in-built algorithms that can monitor the reaction for abnormality, provide flags, and trigger auto-reruns to specimens with abnormal situations in test, such as substrate depletion, oxygen shortage, and hook effects, etc. This intelligent approach with detection, alarming and auto-rerun functions minimizes false results and the risk of a wrong diagnosis, and make reported test result accurate and reliable.